The New Jersey Pharmaceutical Quality Control Association (NJPQCA) holds seven Monthly Luncheon Meetings with a topic of interest to the pharmaceutical industry. The meetings are usually on the third Tuesday of September, October, November, January, February, March, and April at the Galloping Hill Caterers in Union, NJ.
NJPQCA Board held hybrid meetings (in person at the Galloping Hill Caterers and virtually via Webex) for our 2022-2023 season (see table below).
Thank you to all those who attended our 2022-2023 monthly meetings either in person or virtually, and a special thank you to all of our speakers!
Our next meeting will be in September 2023. We will post the 2023-2024 Monthly Meeting Calendar in August.
Don’t forget to check out our Conference page for our upcoming FDA-NJPQCA Conference on May 23rd! We hope you can join us!
| Meeting Date | Topic | Speaker |
|---|---|---|
| September 13, 2022 (hybrid meeting): | Forensics and Innovative Technologies – Analytical Support for the Investigation of Counterfeit Drug Products | Ravi Kalyanaraman, Scientific Director, Forensics & Innovative Technologies, Bristol Myers Squibb |
| October 18, 2022 (hybrid meeting): | US-FDA Surveillance Inspections – Metrics and Trends | Joe Albanese, Ph. D. |
| November 15, 2022 (hybrid meeting): | Major Revisions to EU GMP Annex 1, Manufacture of Sterile Medicinal Products | Manoj Sharma, Ph. D. |
| January 24, 2023 (hybrid meeting): | Nitrosamines – News Companies Need to Know | Andrew Teasdale, Ph. D. |
| February 21, 2023 (hybrid meeting): | Data Integrity – An Informative Discussion | Michael Cutrera |
| March 14, 2023 (hybrid meeting): NOTE CHANGE IN DATE! | Robustness in the Pharmaceutical Import Process | Garrick Heidt |
| April 18, 2023 (hybrid meeting): | USP <660> Glass Containers – Seeking Stakeholder Input | Desmond Hunt, Ph.D., Sr. Principal Scientist, United States Pharmacopeia |
Annual Recognition Event
Our Annual Recognition Event was held Sunday, August 7th. Please see our Board Members webpage for our 2022-2023 Board of Directors.